Target Sufficiency® enables direct, quantitative analysis of drug target systems in cells, biofluids, tissues, and tissue models, including formalin-fixed, paraffin-embedded (FFPE) tissues.
Reduce costs with our complimentary sample for evaluation in your lab.
Inotiv delivers a broad array of nonclinical and analytical services from discovery through clinical development.
Inotiv provides the broadest range of research models and related services to pharmaceutical and biotech companies, government, academia, and other life science organizations.
September 17-20, 2023 Madrid, Spain Inotiv is proud to sponsor the 51st Annual Meeting of the European Teratology Society held September 17-20 in Madrid, Spain. The European Teratolog...
September 18-21, 2023 Brussels, Belgium Join the Inotiv team of experts at the 2023 SPS Annual Meeting held on September 18-21 at the SQUARE Brussels Meeting Centre in Brussels, Belgi...
September 24-27, 2023 Norfolk, VA Join the Inotiv team of experts at the 76th Tobacco Science Research Conference held September 24-27 in Norfolk, VA: Looking Forward – The Challeng...
Inotiv scientists are co-authors on a paper in Regulatory Toxicology and Pharmacology journal, exploring the potential reproductive toxicity of gardenia blue natural food coloring. Natural food colorants ar...
August 29, 2023 WEST LAFAYETTE, Ind., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a lead...
August 24, 2023 WEST LAFAYETTE, Ind., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a lead...
How Differences Between Experimental IBD Models Can Impact Your Drug Development Program
Due to the current FDA concern and guidance on reducing the risk of Nitrosamine impurities in human drugs, there has been an increased industry need for testing of these impurities using the Bacterial Reverse Mutation (Ames) test. As Nitrosamines are not readily detectable by standard Ames methodologies, specifically cited in the Ames testing guideline (OECD 471), the need for a robust protocol better suited for this class of compounds is warranted.
Copyright © Inotiv. All Rights Reserved.